1.
Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T. & Satoh, K. Amelioration by mecobalamin of subclinical carpal tunnel syndrome involving unaffected limbs in stroke patients.
J. Neurol. Sci.
231,
13–18 (2005).
2.
Sato, Y., Maruoka, H. & Oizumi, K. Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation.
Stroke
28,
736–739 (1997).
3.
Sato, Y., Manabe, S., Kuno, H. & Oizumi, K. Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson’s disease.
J. Neurol. Neurosurg. Psychiatry
66,
64–68 (1999).
4.
Sato, Y., Iwamoto, J., Kanoko, T. & Satoh, K. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer’s disease: a randomized controlled trial.
J. Bone Miner. Res.
20,
1327–1333 (2005).
5.
Sato, Y., Iwamoto, J. & Honda, Y. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson’s disease.
Parkinsonism Relat. Disord.
17,
22–26 (2011).
6.
Sato, Y., Metoki, N., Iwamoto, J. & Satoh, K. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients.
Neurology
61,
338–342 (2003).
7.
Sato, Y.
et al.
Amelioration of osteoporosis by menatetrenone in elderly female Parkinson’s disease patients with vitamin D deficiency.
Bone
31,
114–118 (2002).
8.
Sato, Y., Asoh, T., Kaji, M. & Oizumi, K. Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke.
J. Bone Miner. Res.
15,
2487–2494 (2000).
9.
Sato, Y., Honda, Y., Iwamoto, J. & Amano, N. Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease.
J Musculoskelet Neuronal Interact
13,
346–352 (2013).
10.
Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T. & Satoh, K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial.
JAMA
293,
1082–1088 (2005).
11.
Sato, Y., Asoh, T., Metoki, N. & Satoh, K. Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson’s disease.
J. Neurol. Neurosurg. Psychiatry
74,
574–576 (2003).
12.
Iwamoto, J., Takeda, T. & Matsumoto, H. Efficacy of oral bisphosphonates for preventing hip fracture in disabled patients with neurological diseases: a meta-analysis of randomized controlled trials among the Japanese population.
Curr Med Res Opin
27,
1141–1148 (2011).
13.
wamoto, J., Matsumoto, H. & Takeda, T. Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.
Curr Med Res Opin
24,
1379–1384 (2008).
14.
Sato, Y., Iwamoto, J., Kanoko, T. & Satoh, K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial.
Cerebrovasc. Dis.
20,
187–192 (2005).
15.
Sato, Y., Iwamoto, J. & Honda, Y. Once-weekly risedronate for prevention of hip fracture in women with Parkinson’s disease: a randomised controlled trial.
J. Neurol. Neurosurg. Psychiatry
82,
1390–1393 (2011).
16.
Sato, Y., Honda, Y. & Iwamoto, J. RETRACTED: Etidronate for fracture prevention in amyotrophic lateral sclerosis: a randomized controlled trial.
Bone
39,
1080–1086 (2006).
17.
Sato, Y., Kanoko, T., Satoh, K. & Iwamoto, J. RETRACTED: Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer’s disease.
Bone
36,
61–68 (2005).
18.
Sato, Y., Honda, Y. & Iwamoto, J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.
Neurology
68,
911–915 (2007).
19.
Sato, Y., Iwamoto, J., Kanoko, T. & Satoh, K. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.
Arch. Intern. Med.
165,
1743–1748 (2005).
20.
Sato, Y., Iwamoto, J., Kanoko, T. & Satoh, K. Risedronate therapy for prevention of hip fracture after stroke in elderly women.
Neurology
64,
811–816 (2005).
21.
Risedronate therapy for prevention of hip fracture after stroke in elderly women; Risedronate therapy for prevention of hip fracture after stroke in elderly women. Reply from the Authors.
Neurology
87,
239 (2016).
22.
Iwamoto, J., Sato, Y., Takeda, T. & Matsumoto, H. Strategy for prevention of hip fractures in patients with Parkinson’s disease.
World J Orthop
3,
137–141 (2012).
23.
Sato, Y., Kanoko, T., Satoh, K. & Iwamoto, J. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial.
Arch. Intern. Med.
165,
1737–1742 (2005).
